Global Equity Observer
May 17, 2019
Credit Where Credit Is Due

Global Equity Observer

Credit Where Credit Is Due

Credit Where Credit Is Due

Share Icon

May 17, 2019


After a few months of equity market enthusiasm driven by expectations of still decent global gross domestic product (GDP) growth, perennially low interest rates and, at the time of writing, potential resolution of trade tensions, we thought it worthwhile to provide an update on one of the major global tail risks we see – Chinese corporate debt.

Within the private sector in China, total credit rose from 115% of GDP to 207% of GDP between the fourth quarter of 2008 and the first quarter of 2017, according to the Federal Reserve Bank of St. Louis.1 As the International Monetary Fund wrote in its working paper in January 2018, “International experience suggests that such rapid growth is not sustainable and is typically associated with a financial crisis and/or sharp growth slowdown,” 2 a view we share.

The Chinese government seems aware of these risks and began to slow credit growth starting in the first quarter of 2017. The debt-to-GDP ratio has subsequently declined moderately. In particular, the component of credit supply commonly called the shadow banking system declined from an annual supply of ~5-10% of GDP to effectively zero or negative by the middle of 2018.[3] Given the dependence of the Chinese economy on debt supply, this led to a slowdown in GDP expansion. However, in the last few months it appears as though the Chinese government has reversed course to shore up flagging GDP growth. While shadow banking remains subdued, the official banking system has stepped in to offer support by, amongst other things, cutting reserve requirements. This lending effort is directed at privately owned small- and medium-sized enterprises (SME), a sector previously dependent upon the shadow banking system.  

This return to credit growth brings back concerns about a major financial crisis in China as non-performing loans have also been building up. In particular, the fact that banks who had previously not been lending to SMEs are now pushing hard into this higher risk sector is not very reassuring.


We do not have any ability to predict how far the Chinese government is going to push credit growth as a means of maintaining high GDP growth nor whether there will be a return to rapid debt-to-GDP expansion. We nevertheless notice that there are developments that indicate the government is aiming to make the financial system more robust. On one level, supervision has substantially tightened. In 2017 and 2018, the China Banking Regulator Commission (CBRC) issued fines at a run-rate of approximately 1.5 billion renminbi (RMB) – a huge step up from the approximately 100 million RMB run rate issued up until 2016. That tougher approach has resulted in banks gradually unwinding some of the more egregious accounting schemes. For instance, banks used to regularly classify loans as investments by putting a rather flimsy wrapper around the issuance, a practice initially meant as regulatory arbitrage to circumvent loan-to-deposit limits and capital requirements. More recently, these structures were used to reduce the amount of reported non-performing loans, a practice the CBRC is now clamping down on.4 Equally, regulation that allowed loans over 90 days overdue to remain as performing assets is being abolished. These as well as other measures should improve the quality of bank balance sheets in China, in particular amongst the smaller, more vulnerable banks. How fast and how successful this will be depends also on the recovery of the distressed debt market and capacity expansion amongst asset management companies (the Chinese variant of the “bad banks”).  

Hence, we see some positive trends to reduce the tail risk of a financial crisis in China. That being said, the levels of debt are still extraordinarily high, and the pressure to achieve strong GDP growth going forward may still trump the need to achieve medium-term deleveraging. In part, this will also be impacted by the U.S.-China trade negotiations, where a potential failure to agree on a new relationship would trigger more stimulus that supports GDP in the short term but pushes up risks in the long term.

In the case of a new financial crisis, we believe high-quality health care and consumer staples companies would be more resilient"

Our portfolio has an overweight to emerging markets on a revenue basis. The companies we invest in generate an estimated 31% of their revenues in emerging markets versus 22% for the market as a whole. Revenues from China directly account for around 6% (6.0-6.7%) of our global portfolios.5 This exposure is concentrated in consumer staples and health care. We believe these sectors have less exposure to either risk. In case of a slowdown of GDP growth in China, these sectors tend to see far less earnings erosion than the overall market as they enjoy recurring revenues and pricing power. In the case of a new financial crisis, we believe these sectors would be more resilient given the lower leverage. We would suggest that the portfolio offers a good way to gain exposure to the long-term growth prospects of emerging markets in general and China in particular while remaining focused on capital preservation.

With shadow banking subdued, the International Equity Team considers the risks involved in the new Chinese corporate debt.


1 Source:

2 Source:

3 There are various definitions and measurements of the shadow banking system. We use the “Total Social Financing” numbers provided by the People’s Bank of China as well as the Autonomous calculations for shadow banking.

4 Source: UBS, April 2019.

5 Source: Morgan Stanley Investment Management, April 30, 2019.



There is no assurance that a portfolio will achieve its investment objective. Portfolios are subject to market risk, which is the possibility that the market value of securities owned by the portfolio will decline. Accordingly, you can lose money investing in this strategy. Please be aware that this strategy may be subject to certain additional risks. Changes in the worldwide economy, consumer spending, competition, demographics and consumer preferences, government regulation and economic conditions may adversely affect global franchise companies and may negatively impact the strategy to a greater extent than if the strategy's assets were invested in a wider variety of companies. In general, equity securities' values also fluctuate in response to activities specific to a company. Investments in foreign markets entail special risks such as currency, political, economic, and market risks. Stocks of small-capitalization companies carry special risks, such as limited product lines, markets and financial resources, and greater market volatility than securities of larger, more established companies. The risks of investing in emerging market countries are greater than risks associated with investments in foreign developed markets. Non-diversified portfolios often invest in a more limited number of issuers. As such, changes in the financial condition or market value of a single issuer may cause greater volatility. Option writing strategy. Writing call options involves the risk that the Portfolio may be required to sell the underlying security or instrument (or settle in cash an amount of equal value) at a disadvantageous price or below the market price of such underlying security or instrument, at the time the option is exercised. As the writer of a call option, the Portfolio forgoes, during the option's life, the opportunity to profit from increases in the market value of the underlying security or instrument covering the option above the sum of the premium and the exercise price, but retains the risk of loss should the price of the underlying security or instrument decline. Additionally, the Portfolio's call option writing strategy may not fully protect it against declines in the value of the market. There are special risks associated with uncovered option writing which expose the Portfolio to potentially significant loss.

Head of International Equity Team
International Equity Team
Managing Director
International Equity Team
Executive Director
International Equity Team

Gross domestic product (GDP)
is a broad measurement of a nation’s overall economic activity. GDP is the monetary value of all the finished goods and services produced within a country's borders in a specific time period.

This communication is only intended for and will only be distributed to persons resident in jurisdictions where such distribution or availability would not be contrary to local laws or regulations.

Ireland: Morgan Stanley Investment Management (Ireland) Limited. Registered Office: The Observatory, 7-11 Sir John Rogerson’s, Quay, Dublin 2, Ireland. Registered in Ireland under company number 616662. Regulated by the Central Bank of Ireland. United Kingdom: Morgan Stanley Investment Management Limited is authorised and regulated by the Financial Conduct Authority. Registered in England. Registered No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA. Dubai: Morgan Stanley Investment Management Limited (Representative Office, Unit Precinct 3-7th Floor-Unit 701 and 702, Level 7, Gate Precinct Building 3, Dubai International Financial Centre, Dubai, 506501, United Arab Emirates. Telephone: +97 (0)14 709 7158). Germany: Morgan Stanley Investment Management Limited Niederlassung Deutschland Junghofstrasse 13-15 60311 Frankfurt Deutschland (Gattung: Zweigniederlassung (FDI) gem. § 53b KWG). Italy: Morgan Stanley Investment Management Limited, Milan Branch (Sede Secondaria di Milano) is a branch of Morgan Stanley Investment Management Limited, a company registered in the UK, authorised and regulated by the Financial Conduct Authority (FCA), and whose registered office is at 25 Cabot Square, Canary Wharf, London, E14 4QA. Morgan Stanley Investment Management Limited Milan Branch (Sede Secondaria di Milano) with seat in Palazzo Serbelloni Corso Venezia, 16 20121 Milano, Italy, is registered in Italy with company number and VAT number 08829360968. The Netherlands: Morgan Stanley Investment Management, Rembrandt Tower, 11th Floor Amstelplein 1 1096HA, Netherlands. Telephone: 31 2-0462-1300. Morgan Stanley Investment Management is a branch office of Morgan Stanley Investment Management Limited. Morgan Stanley Investment Management Limited is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Switzerland: Morgan Stanley & Co. International plc, London, Zurich Branch Authorised and regulated by the Eidgenössische Finanzmarktaufsicht (“FINMA”). Registered with the Register of Commerce Zurich CHE-115.415.770. Registered Office: Beethovenstrasse 33, 8002 Zurich, Switzerland, Telephone +41 (0) 44 588 1000. Facsimile Fax: +41(0) 44 588 1074.

A separately managed account may not be suitable for all investors. Separate accounts managed according to the Strategy include a number of securities and will not necessarily track the performance of any index. Please consider the investment objectives, risks and fees of the Strategy carefully before investing. A minimum asset level is required. For important information about the investment manager, please refer to Form ADV Part 2.

Please consider the investment objectives, risks, charges and expenses of the funds carefully before investing. The prospectuses contain this and other information about the funds. To obtain a prospectus please download one at or call 1-800-548-7786. Please read the prospectus carefully before investing.

Morgan Stanley Distribution, Inc. serves as the distributor for Morgan Stanley funds.


Hong Kong: This document has been issued by Morgan Stanley Asia Limited for use in Hong Kong and shall only be made available to “professional investors” as defined under the Securities and Futures Ordinance of Hong Kong (Cap 571). The contents of this document have not been reviewed nor approved by any regulatory authority including the Securities and Futures Commission in Hong Kong. Accordingly, save where an exemption is available under the relevant law, this document shall not be issued, circulated, distributed, directed at, or made available to, the public in Hong Kong. Singapore: This document should not be considered to be the subject of an invitation for subscription or purchase, whether directly or indirectly, to the public or any member of the public in Singapore other than (i) to an institutional investor under section 304 of the Securities and Futures Act, Chapter 289 of Singapore (“SFA”); (ii) to a “relevant person” (which includes an accredited investor) pursuant to section 305 of the SFA, and such distribution is in accordance with the conditions specified in section 305 of the SFA; or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. This material has not been reviewed by the Monetary Authority of Singapore. Australia: This publication is disseminated in Australia by Morgan Stanley Investment Management (Australia) Pty Limited ACN: 122040037, AFSL No. 314182, which accept responsibility for its contents. This publication, and any access to it, is intended only for “wholesale clients” within the meaning of the Australian Corporations Act.

Japan: For professional investors, this document is circulated or distributed for informational purposes only. For those who are not professional investors, this document is provided in relation to Morgan Stanley Investment Management (Japan) Co., Ltd. (“MSIMJ”)’s business with respect to discretionary investment management agreements (“IMA”) and investment advisory agreements (“IAA”). This is not for the purpose of a recommendation or solicitation of transactions or offers any particular financial instruments. Under an IMA, with respect to management of assets of a client, the client prescribes basic management policies in advance and commissions MSIMJ to make all investment decisions based on an analysis of the value, etc. of the securities, and MSIMJ accepts such commission. The client shall delegate to MSIMJ the authorities necessary for making investment. MSIMJ exercises the delegated authorities based on investment decisions of MSIMJ, and the client shall not make individual instructions. All investment profits and losses belong to the clients; principal is not guaranteed. Please consider the investment objectives and nature of risks before investing. As an investment advisory fee for an IAA or an IMA, the amount of assets subject to the contract multiplied by a certain rate (the upper limit is 2.16% per annum (including tax)) shall be incurred in proportion to the contract period. For some strategies, a contingency fee may be incurred in addition to the fee mentioned above. Indirect charges also may be incurred, such as brokerage commissions for incorporated securities. Since these charges and expenses are different depending on a contract and other factors, MSIMJ cannot present the rates, upper limits, etc. in advance. All clients should read the Documents Provided Prior to the Conclusion of a Contract carefully before executing an agreement. This document is disseminated in Japan by MSIMJ, Registered No. 410 (Director of Kanto Local Finance Bureau (Financial Instruments Firms)), Membership: the Japan Securities Dealers Association, The Investment Trusts Association, Japan, the Japan Investment Advisers Association and the Type II Financial Instruments Firms Association.

EMEA: This marketing communication has been issued by Morgan Stanley Investment Management (Ireland) Limited (“MSIM Ireland”). Registered Office: The Observatory, 7-11 Sir John Rogerson’s Quay, Dublin 2, Ireland. Registered in Ireland under company number 616662. Regulated by the Central Bank of Ireland.

There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market. Prior to investing, investors should carefully review the strategy’s / product’s relevant offering document. There are important differences in how the strategy is carried out in each of the investment vehicles.

A separately managed account may not be suitable for all investors. Separate accounts managed according to the Strategy include a number of securities and will not necessarily track the performance of any index. Please consider the investment objectives, risks and fees of the Strategy carefully before investing.

This material is a general communication, which is not impartial and has been prepared solely for informational and educational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. The information herein has not been based on a consideration of any individual investor circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision.

Except as otherwise indicated herein, the views and opinions expressed herein are those of the portfolio management team, are based on matters as they exist as of the date of preparation and not as of any future date, and will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing, or changes occurring, after the date hereof.

Forecasts and/or estimates provided herein are subject to change and may not actually come to pass. Information regarding expected market returns and market outlooks is based on the research, analysis and opinions of the authors. These conclusions are speculative in nature, may not come to pass and are not intended to predict the future performance of any specific Morgan Stanley Investment Management product.

MSIM has not authorised financial intermediaries to use and to distribute this document, unless such use and distribution is made in accordance with applicable law and regulation. Additionally, financial intermediaries are required to satisfy themselves that the information in this document is suitable for any person to whom they provide this document in view of that person’s circumstances and purpose. MSIM shall not be liable for, and accepts no liability for, the use or misuse of this document by any such financial intermediary.

The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without MSIM’s express written consent.

All information contained herein is proprietary and is protected under copyright law.


It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.

Privacy & Cookies    •    Terms of Use

©  Morgan Stanley. All rights reserved.